Objectives
This review aimed to systematically evaluate the characteristics of technology‐based interventions (TBIs) and their effectiveness on anxiety, depression, and health‐related quality of life (HRQoL) among patients with prostate cancer.
Methods
We identified eligible research reports published in English language between January 1, 2000, and September 15, 2018, from CINAHL; Embase; “Library and Information Science Abstracts”; “Library, Information Science and Technology Abstracts”; “Library and Information Science Source”; PsychINFO; and PubMed. We abstracted randomized control trials and quasi‐experimental studies that measured the outcomes related to anxiety, depression, or HRQoL. We extracted the data using the Cochrane Handbook for Systematic Reviews of Interventions guideline.
Results
Among the six randomized control trials and four quasi‐experimental studies that met our inclusion criteria, the TBIs aimed to provide informational, psychosocial, self‐care management, and communication support. About 60‐92% of the participants in six studies completed all required contents and 77‐94% of the participants in four studies logged onto the TBI platform. Compared with the patients in usual care, the TBI users reported a significant reduction in anxiety (N=1 study) and depression (N=2 studies) and improvement in HRQoL (N=2 studies). We also identified the limitations of the existing TBI trials.
Conclusions
We found insufficient evidence to support the effectiveness of TBIs in improving health outcomes (anxiety, depression, and HRQOL) among patients with prostate cancer. Future research needs to (1) use rigorous randomized control trials, (2) be sufficiently powered to examine the effects of TBIs, and (3) examine how the effect of TBIs on health outcomes vary by actual intervention use, intervention components, and duration.
Purpose
Illness uncertainty pervades individuals’ experiences of cancer across the illness trajectory and is associated with poor psychological adjustment. This review systematically examined the characteristics and outcomes of interventions promoting illness uncertainty management among cancer patients and/or their family caregivers.
Methods
PubMed, Scopus, PsycINFO, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Embase, and Cochrane Database of Systematic Reviews were systematically searched for relevant literature. We included randomized controlled trials (RCTs) and quasi-experimental studies focusing on interventions for uncertainty management in cancer patients and/or their family caregivers.
Results
Our database searches yielded 26 studies. Twenty interventions were only offered to cancer patients, who were mostly elder, female, and White. All interventions included informational support. Other intervention components included emotional support, appraisal support, and instrumental support. Most interventions were delivered in person and via telephone (n = 8) or exclusively in person (n = 7). Overall, 18 studies identified positive intervention effects on illness uncertainty outcomes.
Conclusion
This systematic review foregrounds the promising potential of several interventions—and especially multi-component interventions—to promote uncertainty management among cancer patients and their family caregivers. To further improve these interventions’ effectiveness and expand their potential impact, future uncertainty management interventions should be tested among more diverse populations using rigorous methodologies.
To prohibit bullying behavior, nurse administrators have to construct a work environment that demonstrates respect and fairness and which is transmitted through nurses' communication pathways.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.